Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors

Details

Ressource 1Download: 35939431_BIB_A5401C2FA2EC.pdf (1084.65 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_A5401C2FA2EC
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Journal
PLOS ONE
Author(s)
Hibar Derrek P., Demetri George D., Peters Solange, Davies Jessica, Humblet Olivier, Maund Sophia L., Perez Laura
ISSN
1932-6203
Publication state
Published
Issued date
08/08/2022
Editor
Vranic Semir
Volume
17
Number
8
Pages
e0270571
Language
english
Keywords
Multidisciplinary
Pubmed
Open Access
Yes
Funding(s)
Fondation Hoffmann-La Roche Ltd.
Create date
10/11/2022 16:11
Last modification date
23/01/2024 7:31
Usage data